The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis
Autor: | Melissa Gresle, Jeanette Lechner-Scott, Trevor J. Kilpatrick, Helmut Butzkueven, Bruce V. Taylor, Michael Barnett, Charmaine Yam, Anneke van der Walt, Tomas Kalincik, David Darby, Jim Stankovich, Daniel Merlo |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
medicine.medical_specialty Multiple Sclerosis Neuropsychological Tests 03 medical and health sciences 0302 clinical medicine Cognition Multiple Sclerosis Relapsing-Remitting medicine Humans 030212 general & internal medicine Psychomotor learning Expanded Disability Status Scale Working memory business.industry Multiple sclerosis Australia Reproducibility of Results General Medicine medicine.disease Test (assessment) Cognitive test Neurology Ambulatory Physical therapy Neurology (clinical) business 030217 neurology & neurosurgery |
Zdroj: | Multiple sclerosis and related disorders. 43 |
ISSN: | 2211-0356 |
Popis: | Monitoring and screening of cognitive function in the ambulatory setting requires simple, brief cognitive tests that are reproducible. MSReactor (MSR) is a web-based platform that screens psychomotor (processing) speed, attention and working memory using a game-like interface. The Processing Speed Test (PST) is a validated computerized version of the Symbol Digit Modalities test (SDMT) and component of the Multiple Sclerosis Performance Test (MSPT).To determine the baseline and 6-month predictive correlations between the MSReactor computerised cognitive battery and the PST.Prospectively enrolled relapsing-remitting multiple sclerosis (RRMS) patients completed the MSR and the PST during 6-monthly clinic visits. Pearson's product-moment coefficients with partial correlation adjustment were calculated between the PST and MSR reaction times for Simple reaction test (SRT), Choice reaction test (CRT) and One- back test (OBK).379 RRMS patients from six tertiary MS centres in Australia were enrolled. The mean age was 40.4 years (SD 10.3) and median Expanded Disability Status Scale (EDSS) score was 1.5 (IQR 1.0 - 2.0). Most (66%) were on high efficacy disease-modifying treatment. Baseline PST scores correlated with the MSR reaction times: SRT (R=-0.40), CRT (R= -0.44) and OBK (R= -0.47), p0.05. There was a moderate correlation between the first visit MSR and 6-month PST test for SRT (R= -0.37, p0.001), CRT (R=-0.44, p 0.001) and OBK (R= -0.43, p 0.001) speed.MSR-measured psychomotor speed, attention and working memory at baseline moderately correlates with baseline and 6-month PST; suggesting overlapping cognitive processes are being tested. Six-month test-retest reliability was acceptable for both tests. |
Databáze: | OpenAIRE |
Externí odkaz: |